VISTAGEN THERAPEUTICS, INC. Liabilities, Noncurrent
VISTAGEN THERAPEUTICS, INC. (VTGN) had Liabilities, Noncurrent of $3.64 million as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2023-11-09
- 2023-09-30: Liabilities, Noncurrent $3.64M.
- 2023-06-30: Liabilities, Noncurrent $4.13M.
- 2023-03-31: Liabilities, Noncurrent $4.44M.
- 2022-12-31: Liabilities, Noncurrent $4.75M.
| Period end | Liabilities, Noncurrent | Liabilities, Noncurrent as first filed |
|---|---|---|
| 2023-09-30 | $3.64M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $4.13M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $4.44M 10-Q · filed 2023-11-09 | |
| 2022-12-31 | $4.75M 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $5.05M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $3.75M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.16M 10-K · filed 2023-06-28 | |
| 2021-12-31 | $4.14M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | $11.93M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $12.02M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $12.11M 10-K · filed 2022-06-23 | |
| 2020-12-31 | $12.48M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $12.75M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $9.11M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $8.73M 10-K · filed 2021-06-29 | |
| 2019-12-31 | $8.49M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $8.25M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $8.01M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $4.14M 10-K · filed 2020-06-29 | |
| 2018-12-31 | $3.86M 10-Q · filed 2019-02-12 | |
| 2018-09-30 | $3.59M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | $3.16M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $2.90M 10-K · filed 2019-06-25 | |
| 2017-12-31 | $2.65M 10-Q · filed 2018-02-12 | |
| 2017-09-30 | $2.40M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $2.04M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $1.73M 10-K · filed 2018-06-26 | |
| 2016-12-31 | $1.42M 10-Q · filed 2017-02-13 | |
| 2016-09-30 | $1.14M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $993.60K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $2.17M 10-K · filed 2017-06-29 | |
| 2015-12-31 | $1.51M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $908.70K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $1.33M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $3.42M 10-K · filed 2016-06-24 | |
| 2014-12-31 | $7.28M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $10.86M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $9.96M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | $7.86M 10-K · filed 2015-06-29 | |
| 2013-12-31 | $8.29M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $9.91M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $9.45M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $7.86M 10-Q · filed 2014-11-19 | $11.02M 10-K · filed 2013-07-18 |
| 2012-12-31 | $8.27M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $3.94M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $2.54M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $11.02M 10-Q · filed 2013-11-14 | $2.87M 10-K · filed 2012-07-02 |
| 2011-12-31 | $2.94M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $3.07M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $3.21M 10-Q · filed 2011-08-22 | |
| 2011-03-31 | $7.85M 10-K · filed 2012-07-02 | $7.85M 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |